• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012462-28
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Syncope (1610); Angina (1710); Cardiac Arrest (1762); Death (1802); Myocardial Infarction (1969); Nausea (1970); Thrombosis (2100); Stenosis (2263)
Event Date 11/15/2016
Event Type  Death  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A cine of the procedure was returned and reviewed by an abbott clinical specialist.The reviewer concluded that there was successful stent and scaffold deployment in the lad, both with good result and flow.The reported patient effects of cardiac arrest, death, myocardial infarction and thrombosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use are known adverse events associated with the use of a coronary scaffold in native coronary arteries.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the us.
 
Event Description
It was reported that the procedure on (b)(6) 2016, was to treat a patient experiencing chronic stable angina with severe coronary artery disease.The proximal and mid left anterior descending artery (lad) had 60% stenosis.It was thought that the proximal lesion was the culprit; therefore a 3.5 x 24 mm non-abbott drug eluting stent was implanted with excellent result.Repeat fractional flow reserve (ffr) indicated hemodynamically severe disease of the mid-lad.Pre-dilatation was performed and a 2.5 x 28 mm absorb scaffold was deployed.Post-dilatation was done with a 3.0 mm balloon with an excellent result.Only some pinching of small septal perforators and diagonal branches were noted, but no dissection was seen and timi 3 flow was achieved.The scaffold seemed well deployed.The patient was transferred to the cardiac care unit overnight.The following day the patient had some nausea, but there were no changes in her electrocardiogram (ecg) and it was thought the cause was the medication (clopidogrel and enoxaparin).The patient was discharged at 11:00 am, after feeling much better.The physician was later informed that once at home, the patient experienced gastrointestinal upset and was given an effervescent antacid powder.The patient lost consciousness and could not be revived.The patient passed away at home that afternoon at 1:30pm.It was confirmed that the patient was given dual antiplatelet drug therapy (dapt) the day she was released.No autopsy was done.The reported cause of death by the physician was acute scaffold thrombosis with acute myocardial infarction, or a malignant ventricular tachyarrhythmia.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6170876
MDR Text Key62265475
Report Number2024168-2016-08825
Device Sequence Number1
Product Code PNY
UDI-Device Identifier08717648156960
UDI-Public(01)08717648156960(17)161112(10)5051861
Combination Product (y/n)N
Reporter Country CodeSF
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 12/13/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/12/2016
Device Catalogue Number1012462-28
Device Lot Number5051861
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/18/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
STENT: 3.5 X 24 MM SYNERGY (BOSTON SCIENTIFIC)
Patient Outcome(s) Death;
Patient Age66 YR
Patient Weight73
-
-